|
 |
TelithromycinThis page contains recent news articles, when available, and an overview of Telithromycin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Telithromycin (when available) Telithromycin is a macrolide antibiotic which has an antimicrobial spectrum similar or slightly wider to that of penicillin, and is often used for people who have an allergy to penicillins. For respiratory tract infections, it has better coverage of atypical organisms, including mycoplasma. It is also used to treat outbreaks of chlamydia, syphilis, and gonorrhea. Telithromycin prevents bacteria from growing, by interfering with their protein synthesis. Telithromycin binds to the subunit 50S of the bacterial ribosome, and thus inhibits the translocation of peptides. For the treatment of Pneumococcal infection;Acute sinusitis;Acute bacterial tonsillitis;Acute bronchitis and bronchiolitis;Lower respiratory tract infection;Lobar (pneumococcal) pneumonia Mechanism Of Action: Telithromycin acts by binding to domains II and V of 23S rRNA of the 50S ribosomal subunit.By binding at domain II, telithromycin retains activity against gram-positive cocci (e.g., Streptococcus pneumoniae )in the presence of resistance mediated by methylases (erm genes)that alter the domain V binding site of telithromycin.Telithromycin may also inhibit the assembly of nascent ribosomal units. News Articles on Telithromycin Data Presented on Cempra Pharmaceutical's CEM-101 at the Infectious Diseases ... - Oct 28, 2009 Activity was slightly better than telithromycin (MIC90 of 0.25 microgram/ml for both; range of less than or equal to 0.008 to 1 for CEM-101 vs. less than or ... Reuters Market Watch - Nov 5, 2009 ...nefazodone, nelfinavir, ritonavir, saquinavir, or telithromycin). The most common adverse effects in clinical trials were respiratory tract infection, ... The Hospitalist Online New drug for type 2 diabetes - Oct 29, 2009 ...nelfinavir, ritonavir, saquinavir, telithromycin). Concomitant sulfonylurea: may need lower dose of sulfonylurea to reduce risk of hypoglycemia. ... Clinical Advisor Neu auf dem Markt - Nov 3, 2009 Umgekehrt ist eine Erhöhung der Plasmakonzentration von Ulipristalacetat durch die Gabe von stark wirksamen CYP3A4-Induktoren wie Ketoconazol, Telithromycin ... Pharmazeutische Zeitung online Antibiotic speeds recovery from asthma attacks - Apr 13, 2006 About half received a daily 800-milligram dose of telithromycin [along with their ... During the 10-day treatment period, those on telithromycin had a 40% ... New Scientist … Update To US Prescribing Information For Ketek(R) (Telithromycin) - Feb 13, 2007 Telithromycin has the potential to prolong the QTc interval of the electrocardiogram ... Thus, telithromycin should be avoided in patients with congenital ... Medical News Today - Medical News Today (press release) Telithromycin, but not montelukast, increases the plasma concentration... - Aug 4, 2005 Lauri I. Kajosaari MB 1 , Mikko Niemi MD 1 , Janne T. Backman MD 1 and Pertti J. Neuvonen MD 1. Correspondence: Janne T. Backman, MD, Department of Clinical ... Nature.com Death reported in patient using new antibiotic - More health news-... - Jan 20, 2006 Federal regulators said they were reviewing an unknown number of US cases involving the drug, telithromycin, and were consulting with their counterparts ... msnbc.com Antibiotics 'could treat asthma' - Apr 12, 2006 One group were given 800 mgs of Telithromycin daily for 10 days while the other ... Symptoms and lung function for the patients in the Telithromycin group ... BBC News US panel backs limiting Sanofi antibiotic uses - Dec 15, 2006 The FDA will make the final decision but usually takes the advice of its advisory panels. The agency approved Ketek, also known generically as telithromycin ... Reuters EU drug watchdog warns on use of Sanofi antibiotic - Mar 30, 2007 Ketek, known generically as telithromycin, already comes with a warning for possible liver damage. Shares of Paris-based Sanofi were 0.9 percent lower at ... Reuters FDA studying Ketek antibiotic - Dec 14, 2006 Ketek, the brand name for telithromycin, is used to treat some types of pneumonia, ... Sanofi said the risks associated with telithromycin appear to be ... CBC.ca Telithromycin (Systemic). - Jul 28, 2005 Telithromycin(tel-ith-roe-MYE-sin) belongs to the family of medicines called antibiotics. Antibiotics are medicines used in the treatment of infections ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Telithromycin (Ketek) for treatment of community-acquired pneumonia.(... - Dec 15, 2007 Telithromycin (Ketek) is a ketolide antimicrobial that was approved in April 2004 for the treatment of several common respiratory infections. ... Free with registration - American Family Physician - AccessMyLibrary.com … Announces Update to Ketek (Telithromycin) US Prescribing Informatio... - Jun 30, 2006 BRIDGEWATER, NJ -- June 30, 2006 -- Sanofi-aventis today announced that the US prescribing information for its antibiotic Ketek(R) (telithromycin) has been ... DG News Telithromycin May Be as Effective as Clarithromycin for... - Oct 13, 2005 Oct. 13, 2005 — For acute exacerbation of chronic bronchitis, telithromycin daily for five days is as effective as 10 days twice daily of clarithromycin and ... Medscape Approval of Antibiotic Worried Safety Officials - Jul 19, 2006 ...“It's as if every principle governing the review and approval of new drugs was abandoned or suspended where telithromycin is concerned,â€? Dr. Graham wrote. ... New York Times Five-Day Telithromycin Once Daily Is As Effective As 10-Day … - Nov 11, 2005 Study objectives: To demonstrate equivalence in the clinical efficacy of telithromycin vs clarithromycin treatment of outpatients with acute exacerbations ... RedOrbit Learn about Telithromycin from Consumer Reports Health. - Jan 4, 2007 Telithromycin may cause worsening of symptoms, including breathing problems, when taken by people ... Full Alert. Telithromycin is used to treat certain ... consumerreports.org … Update to Ketek(R) (Telithromycin) US Prescribing Information - Jun 29, 2006 BRIDGEWATER, NJ, June 29 /PRNewswire-FirstCall/ -- Sanofi-aventis today announced that the US prescribing information for its antibiotic Ketek(R) ... RedOrbit FDA Public Health Advisory: Ketek (Telithromycin) Tablets - Jan 23, 2006 BETHESDA, MD -- January 23, 2006 -- Annals of Internal Medicine published an article on January 20 th reporting three patients who experienced serious liver ... DG News Telithromycin for the treatment of acute bacterial maxillary sinusitis... - Sep 1, 2005 Objective: Telithromycin, the first approved ketolide antibiotic, was developed to treat community-acquired respiratory tract infections, including acute ... $4.95 - Southern Medical Journal - ECNext … Demonstrates Clinical Efficacy of Telithromycin Superior to... - May 24, 2005 SAN DIEGO, May 24 /PRNewswire-FirstCall/ -- Data presented today at the annual International Conference of the American Thoracic Society in San Diego, ... RedOrbit … : Severe Hepatotoxicity of Telithromycin: Three Case Reports and … - Mar 21, 2006 Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine. ... Annals of Internal Medicine … news: EMEA warns on telithromycin.(European Medicines Agency... - Apr 7, 2007 The Agency announced that for the treatment of bronchitis, sinusitis, tonsillitis and pharyngitis, the antibiotic should only be used for infections caused ... Free with registration - Chemist & Druggist - AccessMyLibrary.com Telithromycin-resistant Streptococcus pneumoniae.(LETTERS)(Letter to ... - Sep 1, 2005 To the Editor: In recent years, antimicrobial drug resistance in Streptococcus pneumoniae has increased worldwide and is a major health concern. $4.95 - Emerging Infectious Diseases - ECNext Macrolide- and telithromycin-resistant Streptococcus pyogenes,... - Jun 1, 2005 We found a 13% macrolide resistance in 3866 Streptococcus pyogenes isolated from tonsillopharyngitis patients; 59% macrolide-resistant isolates were ... $4.95 - Emerging Infectious Diseases - ECNext Liver toxicity reported with Ketek.(telithromycin reports liver... - Mar 1, 2006 The Food and Drug Administration is recommending that physicians monitor patients taking telithromycin (Ketek) for signs and symptoms of liver problems in ... Free with registration - Internal Medicine News - AccessMyLibrary.com Study Demonstrates Clinical Efficacy of Telithromycin for Treatment... - May 25, 2005 SAN DIEGO -- Data presented today at the annual International Conference of the American Thoracic Society in San Diego, from the Community-acquired ... Infection Control Today telithromycin Sanofi-Aventis receives recommendation from FDA Joint … - Jan 8, 2007 ...the product in acute exacerbation of chronic bronchitis (AECB) and acute bacterial sinusitis (ABS). This follows a review of the overall benefit-risk ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Antibiotic Ketek (Telithromycin) and Possible Association With Liver ... - Feb 7, 2006 OTTAWA, CANADA -- February 7, 2006 -- Health Canada is advising Canadians about a possible link between use of the antibiotic Ketek and potentially serious ... DG News Asthma; Telithromycin proves successful in tackling symptoms of acute... - May 3, 2006 2006 MAY 3 - (NewsRx.com) -- Researchers have demonstrated that the antibiotic telithromycin is effective at treating acute asthma attacks, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones US FDA restricts use of Sanofi-Aventis' Ketek.(Food and Drug … - Feb 19, 2007 The US Food and Drug Administration has narrowed the approved indications for the controversial antibiotic Ketek (telithromycin), recommending that it ... Free with registration - Pharma Marketletter - AccessMyLibrary.com TELICAST trial of telithromycin produces split results in asthma... - Jul 1, 2006 A double-blind, randomized, placebo-controlled study of the ketolide telithromycin administered orally over a 10-day period to 278 asthma patients ... Free with registration - Formulary - AccessMyLibrary.com Article: Telithromycin for the treatment of acute bacterial maxillary... - Sep 1, 2005 Telithromycin for the treatment of acute bacterial maxillary sinusitis: a review of a new antibacterial agent.(Original Article) ... find Southern Medical ... Pay-Per-View - Southern Medical Journal - HighBeam Research BRIEFLY; Antibiotic's results mixed for asthma - Apr 17, 2006 The study, published in last week's New England Journal of Medicine, found that 278 adults who took the antibiotic telithromycin -- sold by Sanofi-Aventis ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Telithromycin Detrimental in MG Patients - Nov 22, 2006 November 22, 2006 — A new report by French researchers examines 10 cases in which the use of the antibiotic telithromycin ( Ketek, Sanofi-Aventis) was ... Medscape Article: Telithromycin offers a path to tailored treatment in... - Feb 1, 2005 Telithromycin offers a path to tailored treatment in respiratory infections.(Infectious Diseases) ... find Internal Medicine News articles. ORLANDO, FLA. Pay-Per-View - Internal Medicine News - HighBeam Research Important safety information about Ketek (telithromycin). - Oct 4, 2006 Sanofi-aventis Canada Inc, in consultation with Health Canada, has provided new safety information regarding the antibiotic, Ketek (telithromycin) tablets ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Severe Hepatotoxicity with Telithromycin - Mar 20, 2006 Derived from macrolides, ketolides feature side-chain modifications that add acid stability and reduce the development of resistance. Telithromycin was the ... Medscape Telithromycin: hepatic events and myasthenia gravis.(Safety and... - Sep 22, 2006 Canada -- Based on information in published case reports and post-market adverse event reports, the Canadian Product Monograph for telithromycin (Ketek[R]) ... Free with registration - WHO Drug Information - AccessMyLibrary.com Liver failure warning upgraded for telithromycin.(Infectious Diseases) - Aug 1, 2006 The Food and Drug Administration has determined that the antibiotic telithromycin (Ketek) may be associated with serious liver injury and liver failure, ... $4.95 - Internal Medicine News - ECNext Antibiotic Proves Successful In Tackling Symptoms Of Acute Asthma - Apr 16, 2006 The researchers tested telithromycin, an antibiotic made by sanofi-aventis and not currently ... Telithromycin is currently not licensed to treat asthma. ... Medical News Today - Medical News Today (press release) Antibiotic treats asthma attacks - Apr 19, 2006 The researchers tested telithromycin, an antibiotic made by sanofi-aventis and not currently ... Telithromycin is currently not licensed to treat asthma. ... DentalPlans.com … Canada Endorsed Important Safety Information on Ketek (telithromyci... - Oct 3, 2006 Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review, KD Clay et al. (2006) Ann Intern Med 144:415-20 ... DG News Article: Liver toxicity reported with Ketek.(telithromycin reports... - Mar 1, 2006 Liver toxicity reported with Ketek.(telithromycin reports liver toxicity )(Brief article) ... find Internal Medicine News articles. Pay-Per-View - Internal Medicine News - HighBeam Research Implications of Committee Recommendations for Future Drug … - Dec 18, 2006 And I certainly have not prescribed telithromycin, I've never prescribed telithromycin. I have treated both upper and lower respiratory tract infections in ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Clinical Briefs By Louis Kuritzky, MD.(telithromycin for acute... - Jun 29, 2006 By Louis Kuritzky, MD, Clinical Assistant Professor, University of Florida, Gainesville. Dr. Kuritzky is a consultant for GlaxoSmithKline and is on the ... Free with registration - Internal Medicine Alert - AccessMyLibrary.com Antibiotic causes liver toxicity, - Mar 15, 2007 The case of telithromycin is an unusual one. The principle investigator involved in the main pre-approval clinical trial has been sentenced to prison for ... National Review of Medicine EMEA Statement On The Safety Of Ketek (telithromycin), Europe - Jan 29, 2006 The European Medicines Agency (EMEA) has reviewed cases of serious liver injury associated with the use of Ketek (telithromycin). ... Medical News Today - Medical News Today (press release) InBrief: Telithromycin warning.(Brief article) - May 25, 2006 Stronger warnings on the potential for liver toxicity should be added to labelling on antibiotic telithromycin, the US Food and Drug Administration has said ... Free with registration - Pulse - AccessMyLibrary.com Severe Hepatotoxicity of Telithromycin - Sep 19, 2006 In case 1, the patient started to notice dark urine on day 2 of treatment with telithromycin. When his wife noted continued symptoms on day 3, ... Annals of Internal Medicine … failure warning upgraded for telithromycin.(Infectious Diseases) -... - Aug 1, 2006 Liver failure warning upgraded for telithromycin.(Infectious Diseases) ... find Internal Medicine News articles. The Food and Drug Administration has ... Pay-Per-View - Internal Medicine News - HighBeam Research Antibiotics; First ketolide antimicrobial approved - Nov 8, 2005 ..."Telithromycin is the first of the ketolide antibacterials to receive US Food and Drug Administration (FDA) approval for clinical use. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones FDA scraps two Ketek indications.(Infectious Diseases) - Mar 1, 2007 Telithromycin, which is marketed by Sanofi-Aventis as Ketek, is no longer approved to treat acute bacterial sinusitis or acute bacterial exacerbation of ... $4.95 - Internal Medicine News - ECNext … in pediatric studies of telithromycin.(Infectious Diseases) |... - Jul 1, 2006 Company halts enrollment in pediatric studies of telithromycin.(Infectious Diseases) ... find Pediatric News articles. The Food and Drug Administration has ... Pay-Per-View - Pediatric News - HighBeam Research Ketek (telithromycin).(antibiotic labeling approved )(Brief article)... - Aug 1, 2006 Ketek (telithromycin).(antibiotic labeling approved )(Brief article) ... find Medical Marketing & Media articles. Ketek (telithromycin), Sanofi-Aventis' ... Pay-Per-View - Medical Marketing & Media - HighBeam Research FDA Issues Public Health Advisory Concerning Reports of Serious Liver... - Jan 26, 2006 Healthcare providers should monitor patients taking telithromycin for ... Telithromycin should be stopped in patients who develop signs of liver problems. ... Newsinferno.com InBrief: Telithromycin warning - May 25, 2006 Stronger warnings on the potential for liver toxicity should be added to labelling on antibiotic telithromycin, the US Food and Drug Administration has said ... Pay-Per-View - Pulse - Factiva, from Dow Jones åŠ æ‹¿å¤§å?«ç”Ÿéƒ¨å?–æ¶ˆæ³°åˆ©éœ‰ç´ éƒ¨åˆ†é€‚åº”ç—‡ - Sep 21, 2007 ...æ³°åˆ©éœ‰ç´ (telithromycin)是2004å¹´èŽ·å‡†çš„é¦–ä¸ªé…®å†…é…¯ç±»å¹¿è°±æŠ—ç”Ÿç´ ã€‚åŽ»å¹´6月29日，美国FDA 曾ç»?就其è‚?è„?毒性å?‘出è¦ç¤ºå…¬å‘Šï¼Œä½†æœªå¯¹å…¶ä½¿ç”¨ä½œå‡ºé™?制。 ... æ–°å?Žç½‘广东频é?“ FDAå?‘çŽ°æ³°åˆ©éœ‰ç´ å¯¹MGçš„å½±å“? - Nov 7, 2008 Telithromycin（Ketekï¼Œæ³°åˆ©éœ‰ç´ æˆ–è‚¯ç«‹å…‹ï¼‰æ˜¯ä¸€ä¸ªæ–°åž‹çš„å¤§çŽ¯å†…é…¯æŠ—ç”Ÿç´ ï¼Œç›®å‰?å› å‰¯ä½œç”¨ ... 有报é?“表明Telithromycinå?¯æ€¥å‰§åŠ é‡?MG的病情，Perrotç‰[9]回顾性分æž?了10å?? ... ä¸å?Žç½‘ Drug Therapy; Activity of novel macrolides againstHaemophilus … - Feb 1, 2005 Telithromycin was bactericidal against eight of the nine strains. In addition," the authors said "both novel macrolides and telithromycin at two times the ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Cholesterol-lowering drug linked to increased risk of heart attack - Jan 19, 2008 In 2006, the antibiotic Ketek (telithromycin), marketed by French pharmaceutical Sanofi-Aventis, and prescribed more than 5 million times in two years, ... wsws.org Drug Therapy; Activity of novel macrolides againstHaemophilus … - Feb 4, 2005 Telithromycin was bactericidal against eight of the nine strains. In addition," the authors said "both novel macrolides and telithromycin at two times the ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Press Release: Sanofi-Aventis Statement Regarding US FDA Joint … - Dec 15, 2006 KETEK(R) (telithromycin) is indicated in the current labeling for the treatment of ... Information for Ketek(R) (telithromycin ... of a FDA Joint Advisory ... Pay-Per-View - PR Newswire - HighBeam Research Rare Cases of Liver Failure Linked to Antibiotic - Jan 25, 2006 Telithromycin is used to treat respiratory tract bacterial infections. ... One patient improved upon withdrawal of telithromycin. ... RedOrbit Akute Atemnot: Antibiotikum lindert Asthma - Apr 13, 2006 Die andere Hälfte nahm zehn Tage lang 800 Milligramm Telithromycin ein. ... Sowohl die Symptome als auch die Lungenfunktion der Telithromycin-Gruppe ... FOCUS Online FDA evaluates hepatic events linked to Ketek.(News)(Clinical report)... - Jul 1, 2006 The antibiotic Ketek (telithromycin) is neither safe nor effective ... Telithromycin, which is marketed by Sanofi-Aventis as Ketek, is no longer approved to ... Pay-Per-View - Internal Medicine News - HighBeam Research Article: Replidyne halts clinical trial of antibiotic.(Business) -... - Dec 27, 2006 Article: Treatment with Ketek(TM) (telithromycin) Leads to Fewer ... ... Article: KETEK(TM) (telithromycin) Active in Treatment of Acute ... ... Pay-Per-View - Rocky Mountain News - HighBeam Research Article: FDA drops two Ketek indications.(VITAL SIGNS) - Skin &... - Mar 1, 2007 The Food and Drug Administration has eliminated two indications for the antibiotic telithromycin and added a black box warning to its label stating the drug ... Pay-Per-View - Skin & Allergy News - HighBeam Research Bacteria blamed for asthma flare-ups - Apr 30, 2006 Telithromycin belongs to a new class of antibiotics, ketolides, ... Half were randomized to receive the antibiotic telithromycin at 800mg daily for 10 days. ... National Review of Medicine Resistant 'superbugs' create need for novel antibiotics.(Reprint) - Feb 1, 2007 Telithromycin has been designed uniquely to combat DRSP. ... Telithromycin is available as an oral agent and can be taken without regard for meals. ... $4.95 - Dermatology Nursing - ECNext FINDINGS - Jan 21, 2006 The Food and Drug Administration said it was reviewing an unknown number of cases involving the drug, telithromycin, marketed as Ketek, and consulting with ... Pay-Per-View - Washington Post - ProQuest Archiver Liver toxicity reported with Ketek.(Clinical Capsules) | Article from... - Mar 15, 2006 Telithromycin is the first of the ketolide class of antibiotics to be approved ... The FDA recommends telithromycin be stopped in patients who develop signs ... Pay-Per-View - Family Practice News - HighBeam Research Article: Liver failure warning upgraded on antibiotic.(News) - Skin &... - Aug 1, 2006 Telithromycin (Ketek) has not received a black box warning, and both the FDA and Sanofi ... Andrew von Eschenbach on the approval of Ketek (telithromycin). ... Pay-Per-View - Skin & Allergy News - HighBeam Research FDA und EMEA warnen vor Hepatotoxizität von Telithromycin - Jan 23, 2006 Washington - Die amerikanische und die europäische Arzneimittelbehörde FDA haben die Ärzte zur besonderen Umsicht bei der Verordnung des Antibiotikums ... Deutsches Ärzteblatt Article: Liver toxicity reported with Ketek.(Clinical Capsules) -... - Apr 1, 2006 Telithromycin is the first of the ketolide class of antibiotics to be approved ... Journal, since the approval of Ketek (telithromycin) in 2004 ... and Drug ... Pay-Per-View - Skin & Allergy News - HighBeam Research Resistant 'superbugs' create need for novel antibiotics.(Nursing … - Feb 1, 2006 Telithromycin has been designed uniquely to combat DRSP. ... Telithromycin is available as an oral agent and can be taken without regard for meals. ... $4.95 - MedSurg Nursing - ECNext Incidence of NSAID-related liver toxicity climbs fast in California.(N... - Oct 15, 2008 ...telithromycin ... Internal Medicine News; March 1, 2006 ; 700+ words ... Telithromycin is the first of the ketolide class of antibiotics to be approved, ... Pay-Per-View - Internal Medicine News - HighBeam Research Article: US watchdog is accused of playing down drugs risks ; In... - Feb 14, 2007 Article: Treatment with Ketek(TM) (telithromycin) Leads to Fewer ... PR Newswire; September 17, 2003 ; 700+ words ... ... outpatients with AECB, ... Pay-Per-View - Evening Standard - London - HighBeam Research Emergence and spread of Streptococcus pneumoniae with erm(B) and … - Jun 1, 2005 Susceptibility to telithromycin was determined by using the CLSI breakpoints (25): susceptible [less than or equal to] 1 [micro]g/mL: intermediate 2 ... $4.95 - Emerging Infectious Diseases - ECNext Article: FINDINGS - The Washington Post | HighBeam Research - FREE … - Jan 21, 2006 The Food and Drug Administration said it was reviewing an unknown number of cases involving the drug, telithromycin, marketed as Ketek, and consulting with ... Pay-Per-View - Washington Post - HighBeam Research Fossils Fill Gap in Human Lineage - Apr 15, 2006 About half received a daily 800-milligram dose of telithromycin along with their ... During the 10-day treatment period, those on telithromycin had a 40 ... ایران دیلی Article: FDA Restricts Use of Antibiotic - AP Online | HighBeam... - Feb 12, 2007 The FDA in April approved Ketek (telithromycin) tablets from Aventis ... Telithromycin (Ketek) Formulary Evaluation ... of antibacterial drugs that are ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Updates By Carol A. Kemper, MD, FACP. - Jun 1, 2006 Reports of severe, life threatening and even fatal cases of severe liver damage in patients receiving telithromycin (Ketek®, Sanofi Aventis), some of which ... Pay-Per-View - Infectious Disease Alert - Factiva, from Dow Jones Article: Ketek's role in hepatic events under investigation.(News) -... - Jul 1, 2006 According to the Journal, since the approval of Ketek (telithromycin) in 2004, there have been 23 cases of serious liver injury. ... Pay-Per-View - Skin & Allergy News - HighBeam Research Article: Sanofi-Aventis to pause studying controversial antibiotic in... - Jun 8, 2006 Article: KETEK(TM) (telithromycin) Active in Treatment of Acute ... ... Article: Treatment with Ketek(TM) (telithromycin) Leads to Fewer ... ... Pay-Per-View - AP Worldstream - HighBeam Research IDSA/ATS to Release New Guidelines on CAP Diagnosis and Treatment - Oct 19, 2006 ..."There have been some reports of toxicity with telithromycin," said Dr. Mandell, ... However, telithromycin should not be prescribed if the patient has a ... Medscape Lawmakers Demand Answers About Ketek From FDA - Jun 21, 2006 Along with the January 20, Public Announcement, the FDA posted a document titled, “Questions and Answers on Telithromycin (marketed as Ketek),â€? on its web ... scoop.co.nz Article: FDA Subjects Antibiotic to New Scrutiny - AP Online |... - Nov 14, 2006 Article: Treatment with Ketek(TM) (telithromycin) Leads to Fewer ... PR Newswire; September 17, 2003 ; 700+ words ... ... outpatients with AECB, ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Antibiotic Label to Warn of Liver Danger - AP Online |... - Jun 29, 2006 Article: Treatment with Ketek(TM) (telithromycin) Leads to Fewer ... PR Newswire; September 17, 2003 ; 700+ words ... ... outpatients with AECB, ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Antidote.(NEWS) - Medical Marketing & Media | HighBeam … - Jul 1, 2006 Ketek (telithromycin), Sanofi-Aventis' antibiotic, has had new labeling approved ... The FDA in April approved Ketek (telithromycin) tablets from Aventis ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Ketek class action seeks damages over drug's purchase price - Mar 12, 2008 Telithromycin, sold under the brand name Ketek, was approved by the European ... In the US, telithromycin was approved by the FDA for sale and marketing in ... St. Clair Record Basilea Falls as FDA Delays Ceftobiprole Decision Again - Dec 1, 2008 At least one antibiotic, Ketek (telithromycin), was approved despite problems ... The FDA's experience with telithromycin "probably provided the impetus for ... BioWorld Online - BioWorld Online Briefing - Jan 23, 2006 Federal regulators said they were reviewing an unknown number of U.S. cases involving the drug, telithromycin, and were consulting with their counterparts ... Pay-Per-View - Newsday - ProQuest Archiver Article: FDA drops two Ketek indications.(News) - Skin & Allergy News... - Mar 1, 2007 Telithromycin, marketed by Sanofi-Aventis as Ketek, is no longer approved to treat acute ... Finance Committee over Ketek (telithromycin), FDA Feb. ... Pay-Per-View - Skin & Allergy News - HighBeam Research Treating community-acquired bacterial respiratory tract infections:... - Apr 1, 2005 ...(10) The first ketolide, telithromycin, is an alternative to macrolides for the treatment of patients with ABS, ABECB, and CAP. It is highly active against ... $4.95 - Journal of Family Practice - ECNext Liver toxicity reported with Ketek.(Clinical Capsules) - Mar 15, 2006 Telithromycin is the first of the ketolide class of antibiotics to be approved ... The FDA recommends telithromycin be stopped in patients who develop signs ... Pay-Per-View - Family Practice News - Factiva, from Dow Jones FDA scraps two Ketek indications.(Infectious Diseases) | Article from... - Mar 1, 2007 Telithromycin, which is marketed by Sanofi-Aventis as Ketek, is no longer approved to treat acute bacterial sinusitis or acute bacterial exacerbation of ... Pay-Per-View - Internal Medicine News - HighBeam Research Clindamycin-resistant Streptococcus pneumoniae.(Letter to the... - May 1, 2007 For telithromycin, because an E-test strip was unavailable, a microbroth dilution method was used. The strain was susceptible to ceftriaxone (MIC 0.125 ... $4.95 - Emerging Infectious Diseases - ECNext ketolides, Johnson & Johnson Johnson & Johnson preclinical data. - Nov 6, 2006 ...respectively, and the ED50 of telithromycin was 24 mg/kg. ... eight-fold greater for the JNJ ketolides than that for telithromycin. ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Article: Zocor label adds interaction data.(PRODUCTS)(Brief Article) ... - Nov 1, 2005 The label for Zocor (simvastatin) tablets has been changed to include information about drug interactions with telithromycin (Ketek) and danazol (Danocrine) ... Pay-Per-View - Internal Medicine News - HighBeam Research Article: FDA Restricts Use of Antibiotic - AP Online | HighBeam... - Feb 12, 2007 The FDA in April approved Ketek (telithromycin) tablets from Aventis ... Telithromycin (Ketek) Formulary Evaluation ... of antibacterial drugs that are ... Pay-Per-View - Associated Press/AP Online - HighBeam Research NSAID-related hepatotoxicity rose dramatically.(Digestive Disorders)(... - Oct 15, 2008 Family Practice News; March 15, 2006 ; 256 words ... ... physicians monitor patients taking telithromycin (Ketek) for signs and symptoms of liver problems, ... Pay-Per-View - Family Practice News - HighBeam Research Brand Names/Synonyms: Telithromycin is also known by the following brand names and/or synonymsTelithromycin; Ketek (TN); Ketek Drug Category: Telithromycin is categorized under the following by the FDA: Anti-bacterial Agents; Ketolides; ATC:J01FA15 Dosage Forms: TABLET Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 7-(4-dimethylamino-3-hydroxy-6-methyl-tetrahydropyran-2-yl)oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-yl-1H-imidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetraone |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |